Recently, the State Food and Drug Administration (NMPA) issued the Regulations on the Administration of Labeling of Traditional Chinese Medicine Decoction Pieces (hereinafter referred to as the "Regulations"), which specifically regulates the safety requirements of the labeling of traditional Chinese medicine decoction pieces, and clarifies as many as 22 content such as packaging requirements, printing requirements, content requirements, and special labeling of traditional Chinese medicine decoction pieces [1]. It is reported that the "Regulations" will be officially implemented in August this year, as far as the nourishing industry of traditional Chinese medicine decoction pieces is concerned, the new regulations are expected to improve the management level of the industry, and at the same time further standardize the quality of the industry, so that consumers can buy more reassuring and trustworthy traditional Chinese medicine decoction pieces products.
For enterprises producing traditional Chinese medicine decoction pieces, the "Regulations" can not only play a restraining role, but also push the enterprises themselves to shoulder the quality responsibility and continuously improve the production standards and requirements of products. For Guangdong Taisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Taisheng Pharmaceutical"), which has always made products with high standards and strict requirements, the new regulations are a powerful test of Taisheng Pharmaceutical's nourishing achievements over the years.
As a leading enterprise in the nourishing industry, Taisheng Pharmaceutical is deeply engaged in the wholesale of tonic raw materials such as American ginseng, wild ginseng, fish maw, cordyceps sinensis, etc., as well as one-stop supply of ready-to-eat tonic OEM and ODM, with a rich variety of categories, and has also incubated a number of its own brands, such as Baotianhan, Qixiutang, Nanbeichao, Stewed Xiaoyue, etc., at the same time, Taisheng Pharmaceutical continues to improve the quality and service of its brands based on the core advantages of the group. It is worth mentioning that Baotianhan's main business of American ginseng, red ginseng, dendrobium and other traditional Chinese medicine decoction pieces has just completed a comprehensive renewal and upgrade of the brand and launched five series of products, which are deeply loved by consumers.
In the production process of traditional Chinese medicine decoction pieces, Taisheng Pharmaceutical has always adhered to the concept of "selection and authenticity, law-abiding processing, and whole-process quality control", selecting high-quality raw materials from global industrial bases, and bringing safe, effective and convenient tonic products to consumers through sorting, purification, cutting and a variety of deep processing processes.
Returning to the requirements of the new regulations for traditional Chinese medicine decoction pieces, it is not difficult to see that it mainly focuses on the packaging, content, special identification and other aspects of the product, which points out: "The packaging and labeling of traditional Chinese medicine decoction pieces shall be standardized, and the packaging shall be printed or affixed with labels in accordance with the regulations, and accompanied by quality qualification marks." ”
In addition to the 7A-level fully transparent intelligent factory to escort the finishing of decoction pieces, it also realizes the strict quality control of traditional Chinese medicine decoction pieces through a quality control team of more than 60 people, and is committed to letting consumers buy and eat at ease.
In addition, the "Provisions" also encourage the use of new scientific and technological means for the labeling of traditional Chinese medicine decoction pieces, improve the traceability management level of traditional Chinese medicine decoction pieces, and facilitate the query of key quality information. In this regard, in order to ensure the authenticity of product traceability information, Taisheng Pharmaceutical maintains long-term strategic cooperation with authoritative commodity traceability systems and companies, Chinese Academy of Inspection and Quarantine (CAIQ), China Inspection and Certification Group, etc. In the Thaisheng tonic matrix, many categories of products, including dried bird's nest, wild ginseng, instant fish maw, instant bird's nest, etc., have been introduced into the traceability system, through a scientific and strict process system, with a high standard quality foundation, high-quality product supply, high-level technological innovation, high-efficiency and high-quality service, to promote the high-quality development of the industry.
According to the latest policy of the State Food and Drug Administration, Chinese medicine decoction pieces will be allowed to be sold on the open shelf without a prescription, which will also promote the rapid development of the Chinese tonic industry while providing consumers with purchase convenience.
In addition, with the continuous improvement of the public's recognition of Chinese herbal medicines, ready-to-eat tonics, as a new category in the category of medicine and food, also occupy an increasingly important position in the market. In addition to traditional Chinese medicine decoction pieces, Taisheng Pharmaceutical also has its own brand and processing business of ready-to-eat tonic products such as instant fish maw, instant bird's nest, freshly stewed bird's nest, and fish maw porridge.
Throughout recent years, in addition to the "Regulations" for traditional Chinese medicine decoction pieces, the state has also repeatedly issued favorable policies, whether it is due to the further liberalization of policies, or the diversification trend of medicine and food homologous products, related enterprises are expected to usher in a new wave of growth opportunities. As a leading enterprise in the Chinese tonic industry, Taisheng Pharmaceutical has undoubtedly seized the opportunity. It is believed that in the future, Taisheng Pharmaceutical will continue to play a leading role in the industry, actively lead the reform of high-end tonic consumption, and lead the industry to realize the upgrading and standardization of high-end tonics.
Resources:
[1] Announcement of the State Food and Drug Administration on Issuing the "Provisions on the Administration of the Labeling of Traditional Chinese Medicine Decoction Pieces" (No. 90 [2023])